ASCO Recommends Early Integration of Palliative Care for Advanced Cancers

The American Society of Clinical Oncology (ASCO) has updated its guidelines on the integration of palliative care for patients diagnosed with advanced cancer, as well as their caretakers. In essence, the guidelines state that palliative care should be administered as...

Syndros™ Approved for Treating Chemotherapy-Induced Nausea and Vomiting

The orally administered liquid formulation, Syndros (dronabinol), has been approved by the United States Food and Drug Administration (FDA) for the treatment of chemotherapy-induced nausea and vomiting. Syndros is an oral formulation comparable to the pharmaceutical...

Investigational Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers

COLUMBUS, Ohio – New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in...